{
    "name": "cemiplimab",
    "comment": "Rx",
    "other_names": [
        "Libtayo",
        "cemiplimab-rwlc"
    ],
    "classes": [
        "PD-1/PD-L1 Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/libtayo-cemiplimab-1000263",
    "pregnancy": {
        "common": [
            "May cause fetal harm when administered to pregnant females",
            "Verify pregnancy status in females of reproductive potential before initiation",
            "Advise women of the potential risk to a fetus"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Studies in mice demonstrated PD-1/PD-L1 can lead to increased risk of immune-mediated rejection of the developing fetus, resulting in fetal death"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Use effective contraception during treatment and for at least 4 months after last dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data regarding distribution into human milk, or the drug’s effect on breastfed children or on milk production",
            "Advise women not to breastfeed during treatment and for at least 4 months after last dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Infusion-related reactions reported (see Dosage Modifications)",
                "Based on cemiplimab’s mechanism of action, can cause fetal harm when administered to pregnant women"
            ],
            "specific": [
                {
                    "type": "Severe and fatal immune-mediated adverse effects",
                    "description": [
                        "May cause a wide variety of immune-mediated adverse effects",
                        "Incidence and severity of immune-mediated adverse reactions were similar when this drug was administered as single agent or in combination with chemotherapy",
                        "Programmed death receptor-1 (PD-1) or PD-ligand 1 (PD-L1) inhibitors, including cemiplimab, block the PD-1/PD-L1 pathway, thereby removing inhibition of immune response, potentially breaking of peripheral tolerance and induction of immune-mediated adverse reactions",
                        "Immune-mediated pneumonitis, colitis, hepatitis, endocrinopathies, hypophysitis, hypothyroidism or hyperthyroidism, type 1 diabetes mellitus, nephritis, and dermatologic reactions reported ",
                        "Other immune-mediated adverse reactions involving other systems (eg, neurological, cardiovascular, ocular) were also reported in <1% of patients or were reported with other PD-1/PD-L1 blockers",
                        "Usually manifest during treatment and after discontinuation treatment; immune-mediated adverse reactions affecting more than one body system can occur simultaneously",
                        "Immune-mediated dermatologic reactions, including erythema multiforme and pemphigoid, SJS and TEN reported; all dermatologic reactions were treated with systemic corticosteriods in clinical trial; ~22% recurrence of reactions after re-initiation of therapy",
                        "Evaluate clinical chemistries, including liver tests and thyroid function tests, at baseline and periodically during treatment; institute medical management promptly to include specialty consultation as appropriate"
                    ]
                },
                {
                    "type": "Complications of allogeneic hematopoietic stem cell transplantation (HSCT)",
                    "description": [
                        "Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1 inhibitor",
                        "Transplant-related complications include hyperacute graft-versus-host-disease (GVHD), acute GVHD, chronic GVHD, hepatic veno-occlusive disease after reduced-intensity conditioning, and steroid-requiring febrile syndrome (without an identified infectious cause)",
                        "These complications may occur despite intervening therapy between PD-1/PD-L1 blockade and allogeneic HSCT",
                        "Closely monitor for evidence of transplant-related complications and intervene promptly; consider benefit versus risks of treatment with a PD-1/PD-L1 inhibitor before or after an allogeneic HSCT"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Fatigue",
            "percent": "34"
        },
        {
            "name": "Rash",
            "percent": "31"
        },
        {
            "name": "Diarrhea",
            "percent": "25"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "24"
        },
        {
            "name": "Nausea",
            "percent": "21"
        },
        {
            "name": "Pruritus",
            "percent": "18"
        },
        {
            "name": "Cough",
            "percent": "14"
        },
        {
            "name": "Constipation",
            "percent": "13"
        },
        {
            "name": "Anemia",
            "percent": "11"
        },
        {
            "name": "Arthralgia",
            "percent": "11"
        },
        {
            "name": "BCC",
            "percent": "10"
        },
        {
            "name": "H",
            "percent": "3"
        },
        {
            "name": "All grades H",
            "percent": "4"
        },
        {
            "name": "Fatigue",
            "percent": "49"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "33"
        },
        {
            "name": "Diarrhea",
            "percent": "25"
        },
        {
            "name": "Rash",
            "percent": "22"
        },
        {
            "name": "Pruritus",
            "percent": "20"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "15"
        },
        {
            "name": "Decreased appetite",
            "percent": "14"
        },
        {
            "name": "Anemia",
            "percent": "13"
        },
        {
            "name": "Nausea",
            "percent": "12"
        },
        {
            "name": "Urinary tract infection",
            "percent": "12"
        },
        {
            "name": "Headache",
            "percent": "12"
        },
        {
            "name": "Constipation",
            "percent": "11"
        },
        {
            "name": "Dyspnea",
            "percent": "11"
        },
        {
            "name": "Hypertension",
            "percent": "11"
        },
        {
            "name": "Hyponatremia",
            "percent": "3.1"
        },
        {
            "name": "Activated partial thromboplastin time prolonged",
            "percent": "2.3"
        },
        {
            "name": "Lymphocyte count decreased",
            "percent": "2.3"
        },
        {
            "name": "Hypokalemia",
            "percent": "1.5"
        },
        {
            "name": "Hypothyroidism",
            "percent": "10"
        },
        {
            "name": "Decreased appetite",
            "percent": "10"
        },
        {
            "name": "Vomiting",
            "percent": "10"
        },
        {
            "name": "Pneumonitis",
            "percent": "2"
        },
        {
            "name": "Cellulitis",
            "percent": "2"
        },
        {
            "name": "Sepsis",
            "percent": "2"
        },
        {
            "name": "Pneumonia",
            "percent": "2"
        },
        {
            "name": "Lymphopenia",
            "percent": "9"
        },
        {
            "name": "Anemia",
            "percent": "5"
        },
        {
            "name": "Hyponatremia",
            "percent": "5"
        },
        {
            "name": "Hypophosphatemia",
            "percent": "4"
        },
        {
            "name": "Anemia",
            "percent": "4"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "3"
        },
        {
            "name": "Fatigue",
            "percent": "3"
        },
        {
            "name": "Hypercalcemia",
            "percent": "2"
        },
        {
            "name": "Increased AST",
            "percent": "2"
        },
        {
            "name": "Increased INR",
            "percent": "2"
        },
        {
            "name": "Rash",
            "percent": "1"
        },
        {
            "name": "Arthralgia",
            "percent": "1"
        },
        {
            "name": "Urinary tract infection",
            "percent": "1.5"
        },
        {
            "name": "Colitis",
            "percent": "1.5"
        },
        {
            "name": "Acute kidney injury",
            "percent": "1.5"
        },
        {
            "name": "Adrenal insufficiency",
            "percent": "1.5"
        },
        {
            "name": "Anemia",
            "percent": "1.5"
        },
        {
            "name": "Infected neoplasm",
            "percent": "1.5"
        },
        {
            "name": "Somnolence",
            "percent": "1.5"
        },
        {
            "name": "Hypertension",
            "percent": "4.5"
        },
        {
            "name": "Fatigue",
            "percent": "3.8"
        },
        {
            "name": "Urinary tract infection",
            "percent": "2.3"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "1.5"
        },
        {
            "name": "Decreased appetite",
            "percent": "1.5"
        },
        {
            "name": "Headache",
            "percent": "1.5"
        },
        {
            "name": "Acute kidney injury",
            "percent": "1.5"
        },
        {
            "name": "Cachexia",
            "percent": "1.5"
        },
        {
            "name": "Vomiting",
            "percent": "0.5"
        },
        {
            "name": "Constipation",
            "percent": "0.5"
        },
        {
            "name": "Diarrhea",
            "percent": "0.5"
        },
        {
            "name": "Nausea",
            "percent": "0.8"
        },
        {
            "name": "Constipation",
            "percent": "0.8"
        },
        {
            "name": "Rash",
            "percent": "0.8"
        },
        {
            "name": "Anemia",
            "percent": "0.8"
        }
    ]
}